4D Molecular Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
4D Molecular Therapeutics Inc
TickerFDMT
CIK #0001650648
CUSIP35104E100
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
Address5858 Horton Street #455, Emeryville, CA 94608
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
4D Molecular Therapeutics Inc 2018-09-11 90.0 M Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001650648] 10-K
[0001650648] 10-Q
[0001650648] 3
[0001650648] 4
[0001650648] 8-K
[0001650648] D
[0001650648] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
State Street Corp 4D Molecular Therapeutics Inc [2026-05-12] 0.0
Janus Henderson Group PLC 4D Molecular Therapeutics Inc [2026-02-17] 0.0
Novo Holdings A/S 4D Molecular Therapeutics Inc [2025-10-20] 0.0
Goldman Sachs Group Inc 4D Molecular Therapeutics Inc [2024-11-06] 6.9
Vanguard Group Inc 4D Molecular Therapeutics Inc [2024-11-04] 5.32
RA Capital Management LP 4D Molecular Therapeutics Inc [2023-06-05] 6.7
Venrock Healthcare Capital Partners III LP 4D Molecular Therapeutics Inc [2023-05-15] 8.7
Janus Henderson Group PLC 4D Molecular Therapeutics Inc [2022-02-11] 5.1
BlackRock Inc 4D Molecular Therapeutics Inc [2022-02-04] 6.5
Deep Track Capital LP 4D Molecular Therapeutics Inc [2021-11-04] 5.69
Biotechnology Value Fund L P 4D Molecular Therapeutics Inc [2021-07-06] 3.9
Kirn David 4D Molecular Therapeutics Inc [2021-02-16] 7.5
Pfizer Inc 4D Molecular Therapeutics Inc [2021-02-16] 6.3
Schaffer David 4D Molecular Therapeutics Inc [2021-02-16] 7.5
FMR LLC 4D Molecular Therapeutics Inc [2021-02-08] 0.0
Ridgeback Capital Investments LP 4D Molecular Therapeutics Inc [2020-12-23] 5.4
Viking Global Investors LP 4D Molecular Therapeutics Inc [2020-12-21] 14.9
Form 3/4/5 Filer 2011 - 2026
4D Molecular Therapeutics Inc
Bizily Scott
Kirn David
Sblendorio Glenn
Theuer Charles
Miller-Rich Nancy
Gray Susannah
Milligan John F
Chacko Jacob
Tomasello Shawn
Simms Christopher Paul
Gupta Ashoo
Humer Kristian
Mehra Uneek
Kamal Fariborz
Kim Robert Young
Shah Rajeev M
RA Capital Healthcare Fund LP
RA Capital Management LP
Kolchinsky Peter
BVF Inc/IL
Biotechnology Value Trading Fund OS LP
BVF Partners L P/IL
Lampert Mark N
BVF GP Holdings LLC
BVF II GP LLC
BVF Partners OS Ltd
Biotechnology Value Fund L P
Biotechnology Value Fund II LP
BVF I GP LLC
Viking Global Opportunities GP LLC
Viking Global Investors LP
Viking Global Opportunities Illiquid Investments Sub-Master
Viking Global Opportunities Parent GP LLC
Viking Global Opportunities Portfolio GP LLC
Halvorsen Ole Andreas
Shabet Rose Sharon
Ott David C
Kasahara Noriyuki
Moretti August J
Fishman Robert S
Zimmermann Carolyne
Schaffer David
Yao Tony DUNG Ling
Burkoth William T
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Simms Christopher Paul
Stock Option (Right to Buy) · derivative
2026-03-25 Grant 219,000 $0.00
Kirn David
Stock Option (Right to Buy) · derivative
2026-03-25 Grant 750,000 $0.00
Bizily Scott
Stock Option (Right to Buy) · derivative
2026-03-25 Grant 217,000 $0.00
Gupta Ashoo
Common Stock
2026-03-20 Sell 80 $8.61 689
Gupta Ashoo
Restricted Stock Units · derivative
2026-03-20 Option exercise 865 $0.00
Gupta Ashoo
Restricted Stock Units · derivative
2026-03-20 Option exercise 221 $0.00
Gupta Ashoo
Common Stock
2026-03-20 Option exercise 221
Gupta Ashoo
Common Stock
2026-03-20 Option exercise 865
Gupta Ashoo
Common Stock
2026-03-20 Sell 310 $8.61 2,669
Sblendorio Glenn
Stock Option (Right to Buy) · derivative
2026-01-05 Grant 45,000 $0.00
Gupta Ashoo
Restricted Stock Units · derivative
2025-12-20 Option exercise 220 $0.00
Gupta Ashoo
Common Stock
2025-12-20 Sell 310 $8.68 2,691
Gupta Ashoo
Common Stock
2025-12-20 Option exercise 220
Gupta Ashoo
Common Stock
2025-12-20 Sell 79 $8.68 686
Gupta Ashoo
Common Stock
2025-12-20 Option exercise 866
Gupta Ashoo
Restricted Stock Units · derivative
2025-12-20 Option exercise 866 $0.00
Bizily Scott
Common Stock
2025-12-16 Option exercise 1,635 $4.14 6,769
Bizily Scott
Stock Option (Right to Buy) · derivative
2025-12-16 Option exercise 1,635 $0.00
Bizily Scott
Common Stock
2025-12-16 Sell 1,635 $10.90 17,822
Theuer Charles
Common Stock
2025-12-12 Option exercise 9,333 $1.14 10,640
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 152 50,836,193
2025-12-31 153 53,505,527
2025-09-30 135 40,129,783
2025-06-30 121 40,550,721
2025-03-31 128 43,080,853
2024-12-31 147 46,738,350
2024-09-30 141 58,725,247
2024-06-30 145 57,905,190
2024-03-31 152 60,939,939
2023-12-31 113 44,708,731
2023-09-30 112 41,932,871
2023-06-30 101 41,410,505
Form 13F Holdings
Firm Period DFND Voting Shares
Assenagon Asset Management SA [2026-06-30] SOLE 83,333 83,333
Ballentine Partners LLC [2026-06-30] OTR 0 16,359
Gamma Investing LLC [2026-06-30] DFND 1,334 1,334
Allied Private Wealth LLC [2026-06-30] SOLE 740 740
Versant Capital Management Inc [2026-06-30] SOLE 728 728
Fortitude Family Office LLC [2026-06-30] SOLE 134 134
Farther Finance Advisors LLC [2026-06-30] SOLE 0 125
IFP Advisors LLC [2026-06-30] SOLE 78 78
True Wealth Design LLC [2026-06-30] SOLE 0 54
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com